Position in VTRS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$22,718,785
+$18,582,213 QoQ
Shares Held
1,430,654
+208.8% QoQ
Ownership
0.125%
of shares outstanding
% of Portfolio
0.58%
of 13F equity value
Holder Rank
#73
of 1,016 holders
Holding Since
Jun 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Derivatives in VTRS
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$21,126,752
PutShares
1,330,400
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MOORE CAPITAL MANAGEMENT, LP holds $55,694,124 across 7 Drug Manufacturers - Specialty & Generic names. VTRS ranks #1 (40.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
This page
|
1,430,654 | $22,718,785 | |
| 2 | ZTS |
Zoetis Inc.
|
202,749 | $14,569,543 | |
| 3 | BCRX |
Biocryst Pharmaceuticals Inc
|
848,336 | $8,483,360 | |
| 4 | PRGO |
PERRIGO Co plc
|
566,924 | $5,890,340 | |
| 5 | ALKS |
Alkermes plc.
|
76,540 | $4,010,696 | |
| 6 | INCR |
Intercure Ltd.
|
19,455 | $21,400 | |
| 7 | ALVO |
Alvotech
|
50,000 | $0 |
All Filings in VTRS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,718,785 | 1,430,654 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $21,126,752 | 1,330,400 | Put | Sole | 2026-08-14 | |
| 2025-06-30 | $4,136,572 | 463,222 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||